The United States (US) is in the midst of an opioid epidemic. Frontline providers, such as emergency department (ED) nurses, are pivotal in providing care to individuals with pain-related complaints. ED visits related to opioid use have increased across the country, and evidence is mounting that the initial opioid prescription is associated with continued, long-term use (Barnett, Olenski, & Jena, 2017). It has been estimated that nearly 20% of persons taking opioids will misuse their prescription, and four out of five new heroin users began abusing drugs by misusing prescription pain medication (Centers for Disease Control and Prevention [CDC], 2017). The number of opioid overdoses is now five times higher than in 1999, with an average of 115 Americans dying every day from opioids (CDC, 2017). To combat the epidemic many initiatives have been inaugurated. Although the CDC has instituted guidelines for prescribing opioids for chronic pain, there is still ambiguity regarding acute pain prescribing practices. Based upon the extent of opioid misuse in the US, it is clear that the problem requires additional action at many levels.
'Helping to End Addiction Long-Term' (HEAL) is a new, interdisciplinary initiative by The National Institutes of Health (NIH) aimed at improving treatments for opioid misuse addiction and improving pain management (Collins, Koroshetz, & Volkow, 2018; NIH, 2018). While the HEAL initiative has successfully contributed to the strategies for responding to the opioid epidemic, it is not an upstream defense approach to address the treatment of acute pain.
Similarly, the evidence-based, Screening, Brief Intervention and Referral to Treatment (SBIRT) tool, which has been recommended to identify individuals for risky behavior related to current substance use, provides guidance and provision for a brief verbal intervention and referral to treatment, but does not provide guidelines for treating acute pain (Substance Abuse and Mental Health Services Administration [SAMHSA], 2011). SBIRT’s aim is to identify non-dependent substance users for early intervention, thus preempting opioid misuse or abuse (SAMHSA, 2011). However, the opioid naïve individual, who may be at a high risk for a substance use disorder (SUD), potentially falls through the cracks when receiving care in a setting such as the ED.
The use of a predictive model to assess for opioid abuse potential is an approach to mitigate the risk of SUD and addiction. Unfortunately for ED providers, no guidelines for acute pain management exist. In the chronic pain guideline, assessment tools to assess potential for opioid-related harm are discussed. Risk assessment tools that have been evaluated for risk stratification in chronic pain instances include: the opioid risk tool (ORT), screener and opioid assessment for patients with pain, revised (SOAPP-R), and brief risk interview (BRI). Results were inconsistent, and no study evaluated the effectiveness of these mitigation strategies (CDC, 2016).
Assessing an individual’s risk factors for SUD or misuse prior to receiving the first opioid prescription will heighten specific awareness of potential psychiatric and biopsychosocial variables that may predict long-term opioid use and have the potential to impact the opioid crisis long-term (Jones, Schmidt & Moore, 2015). Preventing the transition from initial opioid use to non-prescribed opioid use is key for prescribers. An individual factor that has been found to increase the risk of long-term opioid use is that of diagnosed psychiatric disorders, such as attention deficit and hyperactivity disorders (Mason, 2018). Individuals with mental health diagnoses and a history of non-medical use of prescription drugs have a strong propensity for SUD (McCabe, 2008). Routine screening to assess for misuse or a risk of SUD should be the initial step in prescribing opioids for acute pain. Integrating a screening tool into an electronic medical record may be a feasible approach for conducting an opioid abuse risk assessment (Weiner, Horton, Green, & Butler, 2015a).
Although the CDC guidelines for chronic pain management recommend the use of screening tools, no screening tools have been validated in the ED setting (CDC, 2016). As a result of the opioid epidemic, research has been conducted to evaluate tools regarding patients’ self- report of drug use, and the incidence of persistent drug use post-discharge following an opioid prescription from the ED. However, these are downstream findings and not preventive approaches. The ED setting is a key area in which to implement an opioid misuse or abuse screening tool, though few tools have been studied explicitly for emergency department use (Weiner, Horton, Green, & Butler, 2015b).
Studies are being conducted to evaluate a screening tool for trauma patients so as to identify opioid risk for victims of traumatic injury. Opioid prescribing practices for trauma patients may be modified as a result of this study (Brown et al., 2017). Researchers are evaluating the many independent variables which are included in 18 questionnaires, scales and/or assessment tools. The study is multifactorial with a goal of compiling a tool that will predict opioid misuse or abuse. One screening tool, the Screener for Opioid Assessment for Patients with Pain Revised (SOAPP-R), has been validated in specialty pain clinic practices, but to date has not been adequately studied in the ED. The SOAPP-R was found to perform sub-optimally in the ED, although it may be a feasible tool until further research validates a potential, ED-specific risk potential tool.
Currently, there is no validated tool available for nurses to identify patients who are at risk for misuse and abuse in the ED setting. We are missing an opportunity both for identifying potentially high-risk individuals, such as the opioid naïve patient, and the opportunity for prevention. Guidelines for acute pain management are critical for the provision of appropriate ED care. Organizations that focus on the promotion of safe care and practice must partner to support and conduct research that will ensure the ED is not the gateway to opioid misuse and SUD.
Jeannie Burnie, MS, APRN, AGCNS-BC, CEN, FAEN
Jeannie Burnie has over thirty years of emergency nursing experience. She is the Clinical Nurse Specialist at Bethesda North Hospital, TriHealth, in Cincinnati, Ohio. She received her diploma in nursing from Bethesda Hospital School of Nursing in Cincinnati, OH, in 1986, a Bachelor of Science degree in Nursing from The Medical University of South Carolina, in Charleston, SC, in 1989, and her Master of Science degree, with a focus on the clinical nurse specialist role from Ball State University in Muncie, IN, in 2010. She is active at both the state and local level of the Emergency Nurses Association (ENA) and has written several resolutions surrounding the impact of the opioid epidemic on emergency nurses that have been adopted by the ENA. She has recently completed a research project surrounding the use of an iOS-based educational offering for emergency nurses, and focusing on the safe removal of opioid-overdose victims from personal vehicles, in an effort to strengthen safety practices for emergency nurses.
Angela Clark, PhD, RN
Angela Clark has focused her research on the development and implementation of community-based, harm reduction programs to mitigate the effects of the opioid epidemic. Her research efforts include the development and use of educational materials and fidelity training, along with content experience related to current trends and evidenced-based, best practices for the management of opioid-use disorders. Her original E-learning tools have been recognized by the Apple Distinguished Educators program, and also by the University of Cincinnati with the coveted, E-learning champion award. She is actively involved in several local, regional, and state-level taskforces, and serves on a non-profit Board of Directors at an addiction treatment center. Together the authors have recently completed a grant, funded by the American Nurses Foundation and the Midwest Nursing Research Society, and designed to improve nurse and patient safety when responding to overdose situations in the emergency department.
Barnett, M., Oelnski, A., and Jena, A. (2017). Opioid-prescribing patterns of emergency physicians and risk of long-term use. New England Journal of Medicine, 376(7) 663-673. doi:10.1056/NEJMsa1610524.
Brown, R., Deyo, B., Riley, C., Quanbeck, A., Glass, J., Turpin, R., … Agarwal, S. (2017). Screening in trauma for opioid misuse prevention (STOMP): Study protocol for the development of an opioid risk screening tool for victims of injury. Addiction Science & Clinical Practice, 12(28). doi:10.1186/s13722-017-0097-6
Centers for Disease Control and Prevention (CDC). (2016). Guidelines for prescribing opioids for chronic pain. Retrieved from https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm
Centers for Disease Control and Prevention (CDC). (2017). Opioid overdose: Understanding the epidemic. Retrieved from https://www.cdc.gov/drugoverdose/epidemic/index.html
Collins, F., Koroshetz, W., &Volkow, N. (2018). Helping to end addiction over the long-term, the research plan for the NIH HEAL initiative. Journal of American Medical Association, E1-E2.M. Retrieved from https://jamanetwork.com/journals/jama/article-abstract/2684941
Jones, T., Schmidt, M., & Moore, T. 2015. Further validation of an opioid risk assessment tool: The brief risk questionnaire. Annals of Psychiatry and Mental Health. 3(3).
Mason, M. (2018). Association of psychiatric comorbidity with opioid prescriptions and long-term opioid therapy among US adolescents. Journal of American Medical Association Pediatrics ,172(5), 413-414. doi:10.1001/jamapediatrics.2017.5083
McCabe, S. (2008). Screening for drug abuse among medical and nonmedical users of prescription drugs in a probability sample of college students. Archives Pediatric Adolescent Medicine, 162(3), 225-231. doi: 10.1001/archpediatrics.2007.41
National Institutes of Health. (2018). About the HEAL Initiative. Retrieved from: https://www.nih.gov/research-training/medical-research-initiatives/heal-initiative
Substance Abuse and Mental Health Services Administration (SAMHSA). (2017). About screening brief intervention and referral to treatment (SBIRT). Retrieved from https://www.samhsa.gov/sbirt/about
Weiner, S. Horton, L, Green, T., & Butler, S. (2015a). A comparison of an opioid abuse screening tool and prescription drug monitoring in the emergency department. Drug and Alcohol Dependence. doi:10.106/j.drugalcep.2015.12.007
Weiner, S., Horton, L., Green, T., & Butler, S. (2015b). Feasibility of tablet computer screening for opioid abuse in the emergency department. Western Journal of Emergency Medicine, 16(1). doi:10.5811/westjem.2014.11.23316